Association between PARP-1 polymorphisms and susceptibility to gastric cancer

World Chinese Journal of Digestology

Volumn 18, Issue 14, 2010, Pages 1434-1441

  Kang, Shi Liang ^a   Li, Yu Min ^a   He, Wen Ting ^a   Liu, Tao ^a   Li, Xun ^a   Zhou, Wen Ce ^a   Yi, Jian Fen ^a   Zeng, Xiang Ting ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Gastric cancer; Poly(ADP ribose) polymerase 1; Polymorphism

Indexed keywords

ALANINE; ARGININE; IMMUNOGLOBULIN G ANTIBODY; LYSINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; VALINE;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; COMPUTER PROGRAM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

EID: 77955403948     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v18.i14.1434     Document Type: Article

References (36)

1. Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol 2009; 472: 467-477
2. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol 2006; 12: 17-20 (Pubitemid 43126077)
3. Tsutsumi M, Masutani M, Nozaki T, Kusuoka O, Tsujiuchi T, Nakagama H, Suzuki H, Konishi Y, Sugimura T. Increased susceptibility of poly(ADPribose) polymerase-1 knockout mice to nitrosamine carcinogenicity. Carcinogenesis 2001; 22: 1-3 (Pubitemid 32098137)
4. Nguewa PA, Fuertes MA, Valladares B, Alonso C, Pérez JM. Poly(ADP-ribose) polymerases: homology, structural domains and functions. Novel therapeutical applications. Prog Biophys Mol Biol 2005; 88: 143-172
5. Lockett KL, Hall MC, Xu J, Zheng SL, Berwick M, Chuang SC, Clark PE, Cramer SD, Lohman K, Hu JJ. The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res 2004; 64: 6344-6348 (Pubitemid 39129440)
6. Yea SS, Yang YI, Jang WH, Lee YJ, Bae HS, Paik KH. Association between TNF-alpha promoter polymorphism and Helicobacter pylori cagA subtype infection. J Clin Pathol 2001; 54: 703-706
7. Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, Lunet N. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 2008; 19: 689-701
8. Finishing the euchromatic sequence of the human genome. Nature 2004; 431: 931-945 (Pubitemid 39434409)
9. Cao WH, Wang X, Frappart L, Rigal D, Wang ZQ, Shen Y, Tong WM. Analysis of genetic variants of the poly(ADP-ribose) polymerase-1 gene in breast cancer in French patients. Mutat Res 2007; 632: 20-28 (Pubitemid 47031684)
10. Shiokawa M, Masutani M, Fujihara H, Ueki K, Nishikawa R, Sugimura T, Kubo H, Nakagama H. Genet i c al terat ion of poly(ADP- r ibose) polymerase-1 in human germ cell tumors. Jpn J Clin Oncol 2005; 35: 97-102
11. Zhang X, Miao X, Liang G, Hao B, Wang Y, Tan W, Li Y, Guo Y, He F, Wei Q, Lin D. Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res 2005; 65: 722-726 (Pubitemid 40216429)
12. Yi SY, Lee WJ. A p53 genetic polymorphism of gastric cancer: difference between early gastric cancer and advanced gastric cancer. World J Gastroenterol 2006; 12: 6536-6539 (Pubitemid 44742591)
13. Z h a n g ZW, Newc omb P , Ho l l owo o d A, Moganaden, Gupta J, Feakins R, Storey A, Farthing MJ, Alderson D, Holly J. A comparison study of gastric cancer risk in patients with duodenal and gastric ulcer: roles of gastric mucosal histology and p53 codon 72 polymorphism. Dig Dis Sci 2004; 49: 254-259
14. Haince JF, Rouleau M, Hendzel MJ, Masson JY, Poirier GG. Targeting poly(ADP-ribosyl)ation: a promising approach in cancer therapy. Trends Mol Med 2005; 11: 456-463 (Pubitemid 41415725)
15. Shin VY, Cho CH. Nicotine and gastric cancer. Alcohol 2005; 35: 259-264
16. Levi F, Lucchini F, La Vecchia C. Trends in cancer mortality in Switzerland, 1980-2001. Eur J Cancer Prev 2006; 15: 1-9
17. Zickute J, Strumylaite L, Dregval L, Petrauskiene J, Dudzevicius J, Stratilatovas E. [Vegetables and fruits and risk of stomach cancer] Medicina (Kaunas) 2005; 41: 733-740
18. Liu C, Russell RM. Nutrition and gastric cancer risk: an update. Nutr Rev 2008; 66: 237-249 (Pubitemid 351623967)
19. Franke A, Teyssen S, Singer MV. Alcohol-related diseases of the esophagus and stomach. Dig Dis 2005; 23: 204-213
20. Tanaka K, Kiyohara Y, Kubo M, Matsumoto T, Tanizaki Y, Okubo K, Ninomiya T, Oishi Y, Shikata K, Iida M. Secular trends in the incidence, mortality, and survival rate of gastric cancer in a general Japanese population: the Hisayama study. Cancer Causes Control 2005; 16: 573-578 (Pubitemid 40933627)
21. Romo-González C, Salama NR, Burgeño-Ferreira J, Ponce-Castañeda V, Lazcano-Ponce E, Camorlinga- Ponce M, Torres J. Differences in genome content among Helicobacter pylori isolates from patients with gastritis, duodenal ulcer, or gastric cancer reveal novel disease-associated genes. Infect Immun 2009; 77: 2201-2211
22. Wen S, Moss SF. Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Lett 2009; 282: 1-8
23. Wu CC, Chou PY, Hu CT, Liu ZC, Lin CY, Tseng YH, Lin NT. Clinical Relevance of the vacA, iceA, cagA, and flaA genes of Helicobacter pylori strains isolated in Eastern Taiwan. J Clin Microbiol 2005; 43: 2913-2915
24. Yokoyama K, Higashi H, Ishikawa S, Fujii Y, Kondo S, Kato H, Azuma T, Wada A, Hirayama T, Aburatani H, Hatakeyama M. Functional antagonism between Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT signaling pathway in gastric epithelial cells. Proc Natl Acad Sci U S A 2005; 102: 9661-9666 (Pubitemid 40981737)
25. Atherton JC. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu Rev Pathol 2006; 1: 63-96
26. López-Vidal Y, Ponce-de-León S, Castillo-Rojas G, Barreto-Zúñiga R, Torre-Delgadillo A. High diversity of vacA and cagA Helicobacter pylori genotypes in patients with and without gastric cancer. PLoS One 2008; 3: e3849
27. Nguyen LT, Uchida T, Murakami K, Fujioka T, Moriyama M. Helicobacter pylori virulence and the diversity of gastric cancer in Asia. J Med Microbiol 2008; 57: 1445-1453
28. Ławniczak M, Starzyńska T. [Helicobacter pylori CagA(+) infection in gastric cancer patients] Pol Merkur Lekarski 2002; 13: 216-220
29. Malfertheiner P, Schultze V, Rosenkranz B, Kaufmann SH, Ulrichs T, Novicki D, Norelli F, Contorni M, Peppoloni S, Berti D, Tornese D, Ganju J, Palla E, Rappuoli R, Scharschmidt BF, Del Giudice G. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study. Gastroenterology 2008; 135: 787-795
30. Lundin BS, Enarsson K, Kindlund B, Lundgren A, Johnsson E, Quiding-Järbrink M, Svennerholm AM. The local and systemic T-cell response to Helicobacter pylori in gastric cancer patients is characterised by production of interleukin-10. Clin Immunol 2007; 125: 205-213 (Pubitemid 47570111)